Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Yasunori, Osawa"'
Autor:
Kayo, Osawa, Aiko, Miyaishi, Kazuya, Uchino, Yasunori, Osawa, Natsuko, Inoue, Chiaki, Nakarai, Akimitsu, Tsutou, Yoshiaki, Kido, Masahiro, Yoshimura, Noriaki, Tsubota, Juro, Takahashi
Publikováno v:
Asian Pacific journal of cancer prevention : APJCP. 11(5)
DNA repair enzymes play an important role in the development of various kinds of cancer. We here analyzed associations of XPD Lys751Gln, APEX1 Asp148Glu, XRCC1 Arg399Gln, and XRCC3 Thr241Met gene polymorphisms in DNA repair pathways in relation to th
Autor:
Akimitsu Tsutou, Etsuji Shimada, Yoshiki Tabuchi, Juro Takahashi, Natsuko Inoue, Masahiro Yamamoto, Aiko Miyaishi, Kana Yoshida, Kenichi Tanaka, Yasunori Osawa, Kayo Osawa, Mayumi Kasahara
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 27, Iss 1, p 49 (2008)
Journal of Experimental & Clinical Cancer Research : CR
Journal of Experimental & Clinical Cancer Research : CR
Background Genetic polymorphisms of DNA repair enzymes may lead to genetic instability and colorectal cancer carcinogenesis. Our objective was to measure the interactions between polymorphisms of repair genes and tobacco smoking in colorectal cancer.
Autor:
Kana, Yoshida, Kayo, Osawa, Mayumi, Kasahara, Aiko, Miyaishi, Keiko, Nakanishi, Saori, Hayamizu, Yasunori, Osawa, Akimitsu, Tsutou, Yohiki, Tabuchi, Etsuji, Shimada, Kenichi, Tanaka, Masahiro, Yamamoto, Juro, Takahashi
Publikováno v:
Asian Pacific journal of cancer prevention : APJCP. 8(3)
We investigated CYP1A1*2A, CYP1A1*2C, CYP1A2*1C, CYP1A2*1F, GSTM1 and NAT2 gene polymorphisms, involving enzymes which metabolize many carcinogens, with reference to colorectal cancer risk. The distribution of these genotypes was not associated with
Autor:
Yasunori, Osawa, Kayo Kumar, Osawa, Aiko, Miyaishi, Miho, Higuchi, Akimitsu, Tsutou, Sueo, Matsumura, Yoshiki, Tabuchi, Noriaki, Tsubota, Juro, Takahashi
Publikováno v:
Asian Pacific journal of cancer prevention : APJCP. 8(1)
We investigated the associations between lung cancer and the gene polymorphisms of the drug metabolizing enzymes, containing cytochrome P450 1A1 (CYP1A1), cytochrome P450 1A2 (CYP1A2), glutathione S-transferase class mu (GSTM1), and N-acetyltransfera